Entecavir Tablet, Film Coated
Product Images NDC 69097-425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Entecavir (NDC 69097-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7850ef94 D190 4661 Aaba 075b908a6e86 01

FDA Label Image

7850ef94 D190 4661 Aaba 075b908a6e86 02

7850ef94 D190 4661 Aaba 075b908a6e86 02
This is a prescription drug with the NDC code 69097-426-02. Each tablet contains 0.5 mg of Entecavir USP. It is advised to refer to the package insert for prescribing information. The tablets should be stored in a closed container at a temperature range of 15°C to 30°C (59°F to 86°F) and protected from light. The drug is manufactured by Cipla Lid., Indore SEZ, Pithampur, India, and is distributed by Cipla USA, Inc. in New Jersey. The pharmacist should include the enclosed patient information leaflet when dispensing the drug to the patient. The text also contains a serial number, expiration date, and lot number area for batch overprinting.*
FDA Label Image

7850ef94 D190 4661 Aaba 075b908a6e86 03

7850ef94 D190 4661 Aaba 075b908a6e86 03
NDC 69097-426-05 is a prescription drug containing Entecavir USP 0.5mg. It is available in film-coated tablet form and should be stored in a tightly closed container at 25°C (77°F). The medicine is manufactured by Cipla Ltd in Pithampur, India, and distributed in the United States by Cipla USA, Inc. The package insert contains the full prescribing information and usual dosage instructions. The drug should be kept out of reach of children and protected from light. The pharmacist should dispense the patient information leaflet with the drug product. The expiry date of the 90 tablets is not available.*
FDA Label Image

7850ef94 D190 4661 Aaba 075b908a6e86 04

7850ef94 D190 4661 Aaba 075b908a6e86 04
This is a prescription drug with NDC code 69007-425.02. Each tablet contains 1mg of Entecavir USP. The usual dosage information can be found in the package insert. The tablets should be stored in a tightly closed container at a temperature between 15°C to 30°C (59°F to 86°F), and protected from light. The drug is manufactured by Cipla Ltd. in India, and is distributed in the United States by Cipla USA, Inc. The drug product comes with a Patient Information Leaflet, and the batch information will be overprinted during commercial packing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.